{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:34:56Z","timestamp":1794274496700,"version":"4.9.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2023YFA1801000"],"award-info":[{"award-number":["2023YFA1801000"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2020YFA0803601"],"award-info":[{"award-number":["2020YFA0803601"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2021YFA0805500"],"award-info":[{"award-number":["2021YFA0805500"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"DOI":"10.1038\/s41589-026-02293-z","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T09:02:29Z","timestamp":1786093349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolic reprogramming drives pancreatic \u03b2 cell neogenesis from \u03b1 cells"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9162-7849","authenticated-orcid":false,"given":"Yufeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9593-7167","authenticated-orcid":false,"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-9458","authenticated-orcid":false,"given":"Cenxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-6807","authenticated-orcid":false,"given":"Olga","family":"Babosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie Christopher","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0347-309X","authenticated-orcid":false,"given":"Zhehui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leshi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8341-3350","authenticated-orcid":false,"given":"Lennart","family":"Enders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0855-8343","authenticated-orcid":false,"given":"Stefan","family":"Kubicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9891-3569","authenticated-orcid":false,"given":"Bing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-578X","authenticated-orcid":false,"given":"Biao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6807-2647","authenticated-orcid":false,"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2394-0877","authenticated-orcid":false,"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-1476","authenticated-orcid":false,"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"2293_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/1753-0407.13041","volume":"12","author":"S Matsumoto","year":"2020","unstructured":"Matsumoto, S. & Shimoda, M. Current situation of clinical islet transplantation from allogeneic toward xenogeneic. J. Diabetes 12, 733\u2013741 (2020).","journal-title":"J. Diabetes"},{"key":"2293_CR2","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.stem.2021.10.003","volume":"28","author":"A Ramzy","year":"2021","unstructured":"Ramzy, A. et al. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. Cell Stem Cell 28, 2047\u20132061 (2021).","journal-title":"Cell Stem Cell"},{"key":"2293_CR3","doi-asserted-by":"publisher","first-page":"101477","DOI":"10.1016\/j.molmet.2022.101477","volume":"60","author":"G Basile","year":"2022","unstructured":"Basile, G. et al. Emerging diabetes therapies: bringing back the \u03b2-cells. Mol. Metab. 60, 101477 (2022).","journal-title":"Mol. Metab."},{"key":"2293_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"FW Pagliuca","year":"2014","unstructured":"Pagliuca, F. W. et al. Generation of functional human pancreatic \u03b2 cells in vitro. Cell 159, 428\u2013439 (2014).","journal-title":"Cell"},{"key":"2293_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm.4030","volume":"22","author":"AJ Vegas","year":"2016","unstructured":"Vegas, A. J. et al. Long-term glycemic control using polymer-encapsulated human stem cell-derived \u03b2 cells in immune-competent mice. Nat. Med. 22, 306\u2013311 (2016).","journal-title":"Nat. Med."},{"key":"2293_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41586-019-1168-5","volume":"569","author":"A Veres","year":"2019","unstructured":"Veres, A. et al. Charting cellular identity during human in vitro \u03b2-cell differentiation. Nature 569, 368\u2013373 (2019).","journal-title":"Nature"},{"key":"2293_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng.2215","volume":"44","author":"C Talchai","year":"2012","unstructured":"Talchai, C., Xuan, S., Kitamura, T., DePinho, R. A. & Accili, D. Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nat. Genet. 44, 406\u2013412 (2012).","journal-title":"Nat. Genet."},{"key":"2293_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nature07314","volume":"455","author":"Q Zhou","year":"2008","unstructured":"Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to \u03b2-cells. Nature 455, 627\u2013632 (2008).","journal-title":"Nature"},{"key":"2293_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cell.2009.05.035","volume":"138","author":"P Collombat","year":"2009","unstructured":"Collombat, P. et al. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into \u03b1 and subsequently \u03b2 cells. Cell 138, 449\u2013462 (2009).","journal-title":"Cell"},{"key":"2293_CR10","doi-asserted-by":"publisher","first-page":"716163","DOI":"10.1155\/2014\/716163","volume":"2014","author":"H Luo","year":"2014","unstructured":"Luo, H. et al. Reprogramming of mice primary hepatocytes into insulin-producing cells by transfection with multicistronic vectors. J. Diabetes Res. 2014, 716163 (2014).","journal-title":"J. Diabetes Res."},{"key":"2293_CR11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/nbt.3082","volume":"32","author":"W Li","year":"2014","unstructured":"Li, W. et al. Long-term persistence and development of induced pancreatic \u03b2 cells generated by lineage conversion of acinar cells. Nat. Biotechnol. 32, 1223\u20131230 (2014).","journal-title":"Nat. Biotechnol."},{"key":"2293_CR12","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.celrep.2014.02.013","volume":"6","author":"YJ Chen","year":"2014","unstructured":"Chen, Y. J. et al. De novo formation of insulin-producing \u2018neo-\u03b2 cell islets\u2019 from intestinal crypts. Cell Rep. 6, 1046\u20131058 (2014).","journal-title":"Cell Rep."},{"key":"2293_CR13","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1083\/jcb.201704044","volume":"216","author":"N Druelle","year":"2017","unstructured":"Druelle, N. et al. Ectopic expression of Pax4 in pancreatic \u03b4 cells results in \u03b2-like cell neogenesis. J. Cell Biol. 216, 4299\u20134311 (2017).","journal-title":"J. Cell Biol."},{"key":"2293_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nature13633","volume":"514","author":"S Chera","year":"2014","unstructured":"Chera, S. et al. Diabetes recovery by age-dependent conversion of pancreatic \u03b4-cells into insulin producers. Nature 514, 503\u2013507 (2014).","journal-title":"Nature"},{"key":"2293_CR15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41556-023-01130-y","volume":"25","author":"X Huang","year":"2023","unstructured":"Huang, X. et al. Stomach-derived human insulin-secreting organoids restore glucose homeostasis. Nat. Cell Biol. 25, 778\u2013786 (2023).","journal-title":"Nat. Cell Biol."},{"key":"2293_CR16","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/nature08894","volume":"464","author":"F Thorel","year":"2010","unstructured":"Thorel, F. et al. Conversion of adult pancreatic \u03b1-cells to \u03b2-cells after extreme \u03b2-cell loss. Nature 464, 1149\u20131154 (2010).","journal-title":"Nature"},{"key":"2293_CR17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.cmet.2017.01.009","volume":"25","author":"H Chakravarthy","year":"2017","unstructured":"Chakravarthy, H. et al. Converting adult pancreatic islet \u03b1 cells into \u03b2 cells by targeting both Dnmt1 and Arx. Cell Metab. 25, 622\u2013634 (2017).","journal-title":"Cell Metab."},{"key":"2293_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41586-019-0942-8","volume":"567","author":"K Furuyama","year":"2019","unstructured":"Furuyama, K. et al. Diabetes relief in mice by glucose-sensing insulin-secreting human \u03b1-cells. Nature 567, 43\u201348 (2019).","journal-title":"Nature"},{"key":"2293_CR19","doi-asserted-by":"publisher","first-page":"101832","DOI":"10.1016\/j.xcrm.2024.101832","volume":"5","author":"E Karakose","year":"2024","unstructured":"Karakose, E. et al. Cycling \u03b1 cells in regenerative drug-treated human pancreatic islets may serve as key \u03b2 cell progenitors. Cell Rep. Med. 5, 101832 (2024).","journal-title":"Cell Rep. Med."},{"key":"2293_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cell.2016.11.010","volume":"168","author":"J Li","year":"2017","unstructured":"Li, J. et al. Artemisinins target GABAA receptor signaling and impair \u03b1 cell identity. Cell 168, 86\u2013100 (2017).","journal-title":"Cell"},{"key":"2293_CR21","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.chembiol.2013.10.013","volume":"20","author":"Y Yuan","year":"2013","unstructured":"Yuan, Y. et al. A small-molecule inducer of PDX1 expression identified by high-throughput screening. Chem. Biol. 20, 1513\u20131522 (2013).","journal-title":"Chem. Biol."},{"key":"2293_CR22","doi-asserted-by":"publisher","first-page":"15099","DOI":"10.1073\/pnas.1010018107","volume":"107","author":"D Fomina-Yadlin","year":"2010","unstructured":"Fomina-Yadlin, D. et al. Small-molecule inducers of insulin expression in pancreatic \u03b1-cells. Proc. Natl Acad. Sci. USA 107, 15099\u201315104 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2293_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35544-3","volume":"13","author":"A Martin","year":"2022","unstructured":"Martin, A. et al. A randomized trial of oral \u03b3-aminobutyric acid (GABA) or the combination of GABA with glutamic acid decarboxylase (GAD) on pancreatic islet endocrine function in children with newly diagnosed type 1 diabetes. Nat. Commun. 13, 7928 (2022).","journal-title":"Nat. Commun."},{"key":"2293_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-95751-y","volume":"15","author":"H Hill","year":"2025","unstructured":"Hill, H. et al. Long-term \u03b3-aminobutyric acid (GABA) treatment fails to regain \u03b2-cell function in longstanding type 1 diabetes in a randomized trial. Sci. Rep. 15, 11530 (2025).","journal-title":"Sci. Rep."},{"key":"2293_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm.4036","volume":"22","author":"KH Kim","year":"2016","unstructured":"Kim, K. H. & Roberts, C. W. Targeting EZH2 in cancer. Nat. Med. 22, 128\u2013134 (2016).","journal-title":"Nat. Med."},{"key":"2293_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1470-2045(18)30145-1","volume":"19","author":"A Italiano","year":"2018","unstructured":"Italiano, A. et al. Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study. Lancet Oncol. 19, 649\u2013659 (2018).","journal-title":"Lancet Oncol."},{"key":"2293_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40265-020-01288-x","volume":"80","author":"SM Hoy","year":"2020","unstructured":"Hoy, S. M. Tazemetostat: first approval. Drugs 80, 513\u2013521 (2020).","journal-title":"Drugs"},{"key":"2293_CR28","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.cmet.2018.04.013","volume":"27","author":"TT Lu","year":"2018","unstructured":"Lu, T. T. et al. The polycomb-dependent epigenome controls \u03b2 cell dysfunction, dedifferentiation, and diabetes. Cell Metab. 27, 1294\u20131308 (2018).","journal-title":"Cell Metab."},{"key":"2293_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-023-01707-x","volume":"9","author":"K Al-Hasani","year":"2024","unstructured":"Al-Hasani, K. et al. EZH2 inhibitors promote \u03b2-like cell regeneration in young and adult type 1 diabetes donors. Signal Transduct. Target. Ther. 9, 2 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2293_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-022-01034-7","volume":"7","author":"K Al-Hasani","year":"2022","unstructured":"Al-Hasani, K. et al. Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor. Signal Transduct. Target. Ther. 7, 248 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2293_CR31","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1200\/JCO.19.00799","volume":"37","author":"AJ Armstrong","year":"2019","unstructured":"Armstrong, A. J. et al. ARCHES: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer. J. Clin. Oncol. 37, 2974\u20132986 (2019).","journal-title":"J. Clin. Oncol."},{"key":"2293_CR32","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1056\/NEJMoa1800536","volume":"378","author":"M Hussain","year":"2018","unstructured":"Hussain, M. et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N. Engl. J. Med. 378, 2465\u20132474 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2293_CR33","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1007\/s40618-021-01522-7","volume":"44","author":"P Comeglio","year":"2021","unstructured":"Comeglio, P. et al. Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model. J. Endocrinol. Invest. 44, 2175\u20132193 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"2293_CR34","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/hep4.1571","volume":"4","author":"S Albhaisi","year":"2020","unstructured":"Albhaisi, S. et al. LPCN 1144 resolves NAFLD in hypogonadal males. Hepatol. Commun. 4, 1430\u20131440 (2020).","journal-title":"Hepatol. Commun"},{"key":"2293_CR35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nm.3216","volume":"19","author":"Y Chen","year":"2013","unstructured":"Chen, Y. et al. ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss. Nat. Med. 19, 1023\u20131029 (2013).","journal-title":"Nat. Med."},{"key":"2293_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nature06024","volume":"448","author":"SA Tomlins","year":"2007","unstructured":"Tomlins, S. A. et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448, 595\u2013599 (2007).","journal-title":"Nature"},{"key":"2293_CR37","doi-asserted-by":"publisher","first-page":"8102","DOI":"10.1158\/0008-5472.CAN-09-0941","volume":"69","author":"S Shin","year":"2009","unstructured":"Shin, S. et al. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1\/ETS-related protein 81. Cancer Res. 69, 8102\u20138110 (2009).","journal-title":"Cancer Res."},{"key":"2293_CR38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1101\/gad.211011.112","volume":"27","author":"E Baena","year":"2013","unstructured":"Baena, E. et al. ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients. Genes Dev. 27, 683\u2013698 (2013).","journal-title":"Genes Dev."},{"key":"2293_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2016.03.015","volume":"23","author":"G Navarro","year":"2016","unstructured":"Navarro, G. et al. Extranuclear actions of the androgen receptor enhance glucose-stimulated insulin secretion in the male. Cell Metab. 23, 837\u2013851 (2016).","journal-title":"Cell Metab."},{"key":"2293_CR40","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jdiacomp.2017.03.002","volume":"31","author":"W Xu","year":"2017","unstructured":"Xu, W. et al. Androgen receptor-deficient islet \u03b2-cells exhibit alteration in genetic markers of insulin secretion and inflammation. A transcriptome analysis in the male mouse. J. Diabetes Complications 31, 787\u2013795 (2017).","journal-title":"J. Diabetes Complications"},{"key":"2293_CR41","doi-asserted-by":"publisher","first-page":"dmm052610","DOI":"10.1242\/dmm.052610","volume":"18","author":"AM Baattrup","year":"2025","unstructured":"Baattrup, A. M. et al. ETV1 is a key regulator of enteroendocrine PYY production. Dis. Model. Mech. 18, dmm052610 (2025).","journal-title":"Dis. Model. Mech."},{"key":"2293_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311\u2013326 (2009).","journal-title":"Cell Metab."},{"key":"2293_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41586-021-03827-2","volume":"597","author":"SR Taylor","year":"2021","unstructured":"Taylor, S. R. et al. Dietary fructose improves intestinal cell survival and nutrient absorption. Nature 597, 263\u2013267 (2021).","journal-title":"Nature"},{"key":"2293_CR44","doi-asserted-by":"publisher","first-page":"e1002179","DOI":"10.1371\/journal.pmed.1002179","volume":"13","author":"LA Lotta","year":"2016","unstructured":"Lotta, L. A. et al. Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: a Mendelian randomisation analysis. PLoS Med. 13, e1002179 (2016).","journal-title":"PLoS Med."},{"key":"2293_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/BJ20140697","volume":"468","author":"JA Stamenkovic","year":"2015","unstructured":"Stamenkovic, J. A. et al. Inhibition of the malate\u2013aspartate shuttle in mouse pancreatic islets abolishes glucagon secretion without affecting insulin secretion. Biochem. J. 468, 49\u201363 (2015).","journal-title":"Biochem. J."},{"key":"2293_CR46","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1007\/s00125-011-2249-7","volume":"54","author":"I Goehring","year":"2011","unstructured":"Goehring, I. et al. Identification of an intracellular metabolic signature impairing \u03b2 cell function in the rat \u03b2 cell line INS-1E and human islets. Diabetologia 54, 2584\u20132594 (2011).","journal-title":"Diabetologia"},{"key":"2293_CR47","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.1073\/pnas.1201079109","volume":"109","author":"S Kubicek","year":"2012","unstructured":"Kubicek, S. et al. Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells. Proc. Natl Acad. Sci. USA 109, 5364\u20135369 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2293_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.chembiol.2019.11.004","volume":"27","author":"JH Hsu","year":"2020","unstructured":"Hsu, J. H. et al. EED-targeted PROTACs degrade EED, EZH2, and SUZ12 in the PRC2 complex. Cell Chem. Biol. 27, 41\u201346 (2020).","journal-title":"Cell Chem. Biol."},{"key":"2293_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1021\/acsmedchemlett.5b00037","volume":"6","author":"JE Campbell","year":"2015","unstructured":"Campbell, J. E. et al. EPZ011989, a potent, orally-available EZH2 inhibitor with robust in vivo activity. ACS Med. Chem. Lett. 6, 491\u2013495 (2015).","journal-title":"ACS Med. Chem. Lett."},{"key":"2293_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.molmet.2017.01.003","volume":"6","author":"AM Ackermann","year":"2017","unstructured":"Ackermann, A. M., Zhang, J., Heller, A., Briker, A. & Kaestner, K. H. High-fidelity glucagon-CreER mouse line generated by CRISPR\u2013Cas9 assisted gene targeting. Mol. Metab. 6, 236\u2013244 (2017).","journal-title":"Mol. Metab."},{"key":"2293_CR51","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1158\/2159-8290.CD-19-0152","volume":"9","author":"Z Gu","year":"2019","unstructured":"Gu, Z. et al. Loss of EZH2 reprograms BCAA metabolism to drive leukemic transformation. Cancer Discov. 9, 1228\u20131247 (2019).","journal-title":"Cancer Discov"},{"key":"2293_CR52","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1182\/bloodadvances.2022008242","volume":"7","author":"Y Kikushige","year":"2023","unstructured":"Kikushige, Y. et al. Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function. Blood Adv. 7, 3592\u20133603 (2023).","journal-title":"Blood Adv."},{"key":"2293_CR53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s42255-021-00520-6","volume":"4","author":"QX Ma","year":"2022","unstructured":"Ma, Q. X. et al. BCAA\u2013BCKA axis regulates WAT browning through acetylation of PRDM16. Nat. Metab. 4, 106\u2013122 (2022).","journal-title":"Nat. Metab."},{"key":"2293_CR54","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.cell.2015.10.076","volume":"163","author":"R Suriben","year":"2015","unstructured":"Suriben, R. et al. \u03b2-Cell insulin secretion requires the ubiquitin ligase COP1. Cell 163, 1457\u20131467 (2015).","journal-title":"Cell"},{"key":"2293_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2337\/db21-0077","volume":"71","author":"JK Ofori","year":"2022","unstructured":"Ofori, J. K. et al. Human islet microRNA-200c is elevated in type 2 diabetes and targets the transcription factor ETV5 to reduce insulin secretion. Diabetes 71, 275\u2013284 (2022).","journal-title":"Diabetes"},{"key":"2293_CR56","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00125-013-3096-5","volume":"57","author":"R Gutierrez-Aguilar","year":"2014","unstructured":"Gutierrez-Aguilar, R. et al. The role of the transcription factor ETV5 in insulin exocytosis. Diabetologia 57, 383\u2013391 (2014).","journal-title":"Diabetologia"},{"key":"2293_CR57","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1128\/MCB.23.17.6243-6254.2003","volume":"23","author":"A Goel","year":"2003","unstructured":"Goel, A. & Janknecht, R. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P\/CAF, and HER2\/Neu. Mol. Cell. Biol. 23, 6243\u20136254 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"2293_CR58","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1158\/1535-7163.MCT-13-0689","volume":"13","author":"MS Pop","year":"2014","unstructured":"Pop, M. S. et al. A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein. Mol. Cancer Ther. 13, 1492\u20131502 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"2293_CR59","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.1168175","volume":"324","author":"C Tran","year":"2009","unstructured":"Tran, C. et al. Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science 324, 787\u2013790 (2009).","journal-title":"Science"},{"key":"2293_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.15252\/embr.201540946","volume":"17","author":"J Li","year":"2016","unstructured":"Li, J. et al. Single-cell transcriptomes reveal characteristic features of human pancreatic islet cell types. EMBO Rep. 17, 178\u2013187 (2016).","journal-title":"EMBO Rep."},{"key":"2293_CR61","doi-asserted-by":"publisher","first-page":"101329","DOI":"10.1016\/j.molmet.2021.101329","volume":"54","author":"T Casteels","year":"2021","unstructured":"Casteels, T. et al. An inhibitor-mediated \u03b2-cell dedifferentiation model reveals distinct roles for FOXO1 in glucagon repression and insulin maturation. Mol. Metab. 54, 101329 (2021).","journal-title":"Mol. Metab."},{"key":"2293_CR62","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nprot.2012.024","volume":"7","author":"M Yuan","year":"2012","unstructured":"Yuan, M., Breitkopf, S. B., Yang, X. & Asara, J. M. A positive\/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat. Protoc. 7, 872\u2013881 (2012).","journal-title":"Nat. Protoc."},{"key":"2293_CR63","doi-asserted-by":"publisher","first-page":"101060","DOI":"10.1016\/j.molmet.2020.101060","volume":"42","author":"C Berthault","year":"2020","unstructured":"Berthault, C., Staels, W. & Scharfmann, R. Purification of pancreatic endocrine subsets reveals increased iron metabolism in \u03b2 cells. Mol. Metab. 42, 101060 (2020).","journal-title":"Mol. Metab."},{"key":"2293_CR64","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00109-015-1377-9","volume":"94","author":"CE Zois","year":"2016","unstructured":"Zois, C. E. & Harris, A. L. Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy. J. Mol. Med. 94, 137\u2013154 (2016).","journal-title":"J. Mol. Med."},{"key":"2293_CR65","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.kint.2019.10.020","volume":"97","author":"M Ito","year":"2020","unstructured":"Ito, M. et al. Prolyl hydroxylase inhibition protects the kidneys from ischemia via upregulation of glycogen storage. Kidney Int. 97, 687\u2013701 (2020).","journal-title":"Kidney Int."},{"key":"2293_CR66","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nchembio.2382","volume":"13","author":"MP Licciardello","year":"2017","unstructured":"Licciardello, M. P. et al. A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor. Nat. Chem. Biol. 13, 771\u2013778 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"2293_CR67","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2337\/db20-1115","volume":"70","author":"MSH Friedlander","year":"2021","unstructured":"Friedlander, M. S. H., Nguyen, V. M., Kim, S. K. & Bevacqua, R. J. Pancreatic pseudoislets: an organoid archetype for metabolism research. Diabetes 70, 1051\u20131060 (2021).","journal-title":"Diabetes"},{"key":"2293_CR68","doi-asserted-by":"publisher","first-page":"111288","DOI":"10.1016\/j.celrep.2022.111288","volume":"40","author":"T Casteels","year":"2022","unstructured":"Casteels, T. et al. SMNDC1 links chromatin remodeling and splicing to regulate pancreatic hormone expression. Cell Rep. 40, 111288 (2022).","journal-title":"Cell Rep."},{"key":"2293_CR69","doi-asserted-by":"publisher","first-page":"eadx8909","DOI":"10.1126\/scitranslmed.adx8909","volume":"18","author":"H Zhu","year":"2026","unstructured":"Zhu, H. et al. Epigenetically regulated pancreatic GABA\u2013somatostatin signaling underlies gestational diabetes-induced glucose intolerance in offspring. Sci. Transl. Med. 18, eadx8909 (2026).","journal-title":"Sci. Transl. Med."},{"key":"2293_CR70","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno, G. et al. RNA velocity of single cells. Nature 560, 494\u2013498 (2018).","journal-title":"Nature"},{"key":"2293_CR71","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.12.006","volume":"172","author":"I Piazza","year":"2018","unstructured":"Piazza, I. et al. A map of protein\u2013metabolite interactions reveals principles of chemical communication. Cell 172, 358\u2013372 (2018).","journal-title":"Cell"},{"key":"2293_CR72","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84\u201387 (2013).","journal-title":"Science"},{"key":"2293_CR73","doi-asserted-by":"publisher","first-page":"20925","DOI":"10.1073\/pnas.1212870110","volume":"109","author":"B Leibiger","year":"2012","unstructured":"Leibiger, B. et al. Glucagon regulates its own synthesis by autocrine signaling. Proc. Natl Acad. Sci. USA 109, 20925\u201320930 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2293_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49537-x","volume":"15","author":"L Liu","year":"2024","unstructured":"Liu, L. et al. Intra-islet \u03b1-cell Gs signaling promotes glucagon release. Nat. Commun. 15, 5129 (2024).","journal-title":"Nat. Commun."},{"key":"2293_CR75","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/1753-0407.13347","volume":"15","author":"W Fu","year":"2023","unstructured":"Fu, W., Hongwei, J. & Li, J. Artemether treatment improves islet function and metabolic homeostasis in diabetic nonhuman primates. J. Diabetes 15, 76\u201380 (2023).","journal-title":"J. Diabetes"},{"key":"2293_CR76","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1134\/S1607672924600386","volume":"518","author":"F Yazdanimoghaddam","year":"2024","unstructured":"Yazdanimoghaddam, F. et al. Long-term GABA supplementation regulates diabetic gastroenteropathy through GABA receptor\/trypsin-1\/PARs\/AKT\/COX-2 axis. Dokl. Biochem. Biophys. 518, 452\u2013462 (2024).","journal-title":"Dokl. Biochem. Biophys."},{"key":"2293_CR77","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S1470-2045(20)30441-1","volume":"21","author":"F Morschhauser","year":"2020","unstructured":"Morschhauser, F. et al. Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial. Lancet Oncol. 21, 1433\u20131442 (2020).","journal-title":"Lancet Oncol."},{"key":"2293_CR78","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1158\/1078-0432.CCR-23-3383","volume":"30","author":"NJ Choudhury","year":"2024","unstructured":"Choudhury, N. J. et al. A phase I\/II study of valemetostat (DS-3201b), an EZH1\/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer. Clin. Cancer Res. 30, 3697\u20133703 (2024).","journal-title":"Clin. Cancer Res."},{"key":"2293_CR79","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S2352-3026(22)00134-X","volume":"9","author":"Y Song","year":"2022","unstructured":"Song, Y. et al. SHR2554, an EZH2 inhibitor, in relapsed or refractory mature lymphoid neoplasms: a first-in-human, dose-escalation, dose-expansion, and clinical expansion phase 1 trial. Lancet Haematol. 9, e493\u2013e503 (2022).","journal-title":"Lancet Haematol."},{"key":"2293_CR80","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41586-024-07291-6","volume":"629","author":"F Li","year":"2024","unstructured":"Li, F. et al. Sex differences orchestrated by androgens at single-cell resolution. Nature 629, 193\u2013200 (2024).","journal-title":"Nature"},{"key":"2293_CR81","doi-asserted-by":"publisher","first-page":"115188","DOI":"10.1016\/j.celrep.2024.115188","volume":"44","author":"J Chen","year":"2025","unstructured":"Chen, J., Wu, Y., Hao, W., You, J. & Wu, L. Non-canonical hepatic androgen receptor mediates glucagon sensitivity in female mice through the PGC1\u03b1\/ERR\u03b1\/mitochondria axis. Cell Rep. 44, 115188 (2025).","journal-title":"Cell Rep"},{"key":"2293_CR82","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644\u2013648 (2005).","journal-title":"Science"},{"key":"2293_CR83","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrurol.2009.127","volume":"6","author":"JP Clark","year":"2009","unstructured":"Clark, J. P. & Cooper, C. S. ETS gene fusions in prostate cancer. Nat. Rev. Urol. 6, 429\u2013439 (2009).","journal-title":"Nat. Rev. Urol."},{"key":"2293_CR84","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nature09409","volume":"467","author":"P Chi","year":"2010","unstructured":"Chi, P. et al. ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours. Nature 467, 849\u2013853 (2010).","journal-title":"Nature"},{"key":"2293_CR85","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/CIRCRESAHA.118.313036","volume":"123","author":"C Rommel","year":"2018","unstructured":"Rommel, C. et al. The transcription factor ETV1 induces atrial remodeling and arrhythmia. Circ. Res. 123, 550\u2013563 (2018).","journal-title":"Circ. Res."},{"key":"2293_CR86","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.120.048121","volume":"143","author":"N Yamaguchi","year":"2021","unstructured":"Yamaguchi, N. et al. Cardiac pressure overload decreases ETV1 expression in the left atrium, contributing to atrial electrical and structural remodeling. Circulation 143, 805\u2013820 (2021).","journal-title":"Circulation"},{"key":"2293_CR87","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1172\/JCI87968","volume":"126","author":"A Shekhar","year":"2016","unstructured":"Shekhar, A. et al. Transcription factor ETV1 is essential for rapid conduction in the heart. J. Clin. Invest. 126, 4444\u20134459 (2016).","journal-title":"J. Clin. Invest."},{"key":"2293_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28239-7","volume":"8","author":"A Shekhar","year":"2018","unstructured":"Shekhar, A. et al. ETV1 activates a rapid conduction transcriptional program in rodent and human cardiomyocytes. Sci. Rep. 8, 9944 (2018).","journal-title":"Sci. Rep."},{"key":"2293_CR89","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41591-023-02704-x","volume":"30","author":"K Fizazi","year":"2024","unstructured":"Fizazi, K. et al. First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial. Nat. Med. 30, 257\u2013264 (2024).","journal-title":"Nat. Med."},{"key":"2293_CR90","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1056\/NEJMoa1903835","volume":"381","author":"ID Davis","year":"2019","unstructured":"Davis, I. D. et al. Enzalutamide with standard first-line therapy in metastatic prostate cancer. N. Engl. J. Med. 381, 121\u2013131 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2293_CR91","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0140-6736(23)01055-3","volume":"402","author":"N Agarwal","year":"2023","unstructured":"Agarwal, N. et al. Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial. Lancet 402, 291\u2013303 (2023).","journal-title":"Lancet"},{"key":"2293_CR92","doi-asserted-by":"publisher","first-page":"eadf2034","DOI":"10.1126\/science.adf2034","volume":"388","author":"EM Walker","year":"2025","unstructured":"Walker, E. M. et al. Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissues. Science 388, eadf2034 (2025).","journal-title":"Science"},{"key":"2293_CR93","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2020.02.048","volume":"180","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Long-term expansion of pancreatic islet organoids from resident PROCR+ progenitors. Cell 180, 1198\u20131211 (2020).","journal-title":"Cell"},{"key":"2293_CR94","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4161\/isl.3.6.17704","volume":"3","author":"V Venkatesan","year":"2011","unstructured":"Venkatesan, V., Gopurappilly, R., Goteti, S. K., Dorisetty, R. K. & Bhonde, R. R. Pancreatic progenitors: the shortest route to restore islet cell mass. Islets 3, 295\u2013301 (2011).","journal-title":"Islets"},{"key":"2293_CR95","doi-asserted-by":"publisher","first-page":"100466","DOI":"10.1016\/j.xcrm.2021.100466","volume":"2","author":"AMJ Shapiro","year":"2021","unstructured":"Shapiro, A. M. J. et al. Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device. Cell Rep. Med. 2, 100466 (2021).","journal-title":"Cell Rep. Med."},{"key":"2293_CR96","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.stem.2021.11.008","volume":"28","author":"EJP de Koning","year":"2021","unstructured":"de Koning, E. J. P. & Carlotti, F. Stem cell-based islet replacement therapy in diabetes: a road trip that reached the clinic. Cell Stem Cell 28, 2044\u20132046 (2021).","journal-title":"Cell Stem Cell"},{"key":"2293_CR97","unstructured":"Krueger, F. et al. FelixKrueger\/TrimGalore: v0.6.10\u2014add default decompression path. Zenodo https:\/\/zenodo.org\/records\/7598955 (2023)."},{"key":"2293_CR98","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2293_CR99","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290\u2013295 (2015).","journal-title":"Nat. Biotechnol."},{"key":"2293_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2293_CR101","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"2293_CR102","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/bioinformatics\/bty648","volume":"35","author":"B Langmead","year":"2019","unstructured":"Langmead, B., Wilks, C., Antonescu, V. & Charles, R. Scaling read aligners to hundreds of threads on general-purpose processors. Bioinformatics 35, 421\u2013432 (2019).","journal-title":"Bioinformatics"},{"key":"2293_CR103","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"2293_CR104","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"2293_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP\u2013seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"2293_CR106","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"2293_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27055-4","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer. Nat. Commun. 12, 7139 (2021).","journal-title":"Nat. Commun."},{"key":"2293_CR108","doi-asserted-by":"publisher","first-page":"E692","DOI":"10.1152\/ajpendo.00193.2025","volume":"329","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. \u03b1 Cells transdifferentiate into \u03b4 cells during the progression of autoimmunity in nondiabetic NOD mice. Am. J. Physiol. Endocrinol. Metab. 329, E692\u2013E706 (2025).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2293_CR109","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41422-024-01038-8","volume":"35","author":"W Fu","year":"2025","unstructured":"Fu, W. et al. Neurotensin\u2013neurotensin receptor 2 signaling in adipocytes suppresses food intake through regulating ceramide metabolism. Cell Res. 35, 117\u2013131 (2025).","journal-title":"Cell Res."},{"key":"2293_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18071-x","volume":"11","author":"I Piazza","year":"2020","unstructured":"Piazza, I. et al. A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes. Nat. Commun. 11, 4200 (2020).","journal-title":"Nat. Commun."},{"key":"2293_CR111","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari, R. et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 9, 2100\u20132122 (2014).","journal-title":"Nat. Protoc."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02293-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02293-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02293-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:03:37Z","timestamp":1788800617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02293-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":111,"alternative-id":["2293"],"URL":"https:\/\/doi.org\/10.1038\/s41589-026-02293-z","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lu Zhou, J.L., H.H., Y.Z. and W.X. are the inventors of China patent ZL 2022 1 1126387.6, \u2018Application of 6-phosphogluconate and its derivatives in the preparation of drugs for preventing or treating glucose metabolism disorders\u2019 (granted). The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}